| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.059 | 0.8 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | 0.061 | 0.8 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.015 | 0.8 |